Top 7 Things You Must Know About Corneal Transplant

Author : Sanchitarora
Publish Date : 2020-05-22


Top 7 Things You Must Know About Corneal Transplant

Corneal transplant is done to replace the damaged cornea from the eye of an individual. The damaged cornea is replaced by a donor cornea. An experienced ophthalmologist performs this operation and it is done in a well-equipped eye hospital.

But before you undergo this treatment, you should know the 7 most important things about this treatment procedure. These are as follows:

Who Can Undergo a Corneal Transplant?

Eye candidates who have got an unhealthy or damaged cornea need a corneal transplant. One must consult the best cornea specialist in India who can evaluate the eye condition, run some tests and better advice if the transplant is the right treatment for the patient. There could be various reasons for a damaged cornea that the doctor needs to identify before operating.

Right Candidate For Transplant

For corneal transplant the candidates with the following conditions are suitable:

  • Swollen or scarred cornea.
  • A genetic disorder called Fuch’s dystrophy.
  • Severe infection in the cornea.
  • Thinned or misshapen cornea.
  • Advanced keratoconus.

Types Of Corneal Transplant Recommended

Depending upon the cornea’s condition, the eye specialist may suggest a suitable type of corneal transplant program. There are three ways to do the corneal transplant and they are:

  • A full-thickness transplant is recommended when the inner and outer layer of the cornea gets damaged. This process is called the Penetrating Keratoplasty.
  • Some may have partial corneal damage. In such cases, the doctor may recommend a partial transplant where only the damaged part of the cornea is removed.
  • If the patient's innermost corneal tissue is damaged, then Endothelial Keratoplasty is done.

What Happens Before The Corneal Transplant?

The eye surgeon will administer either local or general anesthesia before the corneal transplant procedure. There are also some physical check-ups done to see if the patient is fit enough for the treatment.

Duration For Recovery

Corneal transplant patients recover within a couple of days. But the recovery phase may vary from person to person depending upon the physical conditions. Post-surgery the patients are given protective eyewear so that the new cornea does not get exposed initially. It would take time to adjust to the body.

For a couple of weeks, the patient will need to visit the doctor for checkups to ensure that there is no sign of infection or other side effects. The patient needs to follow all the instructions given by the doctor to speed up the recovery.

Risk Factors Involved In Corneal Transplant

Generally, a corneal transplant is a safe procedure. The only risk factor is that sometimes the donor corneal tissue may get rejected by your body. But the chances of rejection are low and one must consult with the doctor to discuss the risks and complications. The donor tissue rejection signs include redness, pain, swelling and watery eyes. In case you see any of these signs, make sure to consult with your eye surgeon.

Longevity Of The Donor Cornea

Corneal transplant is a permanent treatment. The corneal tissue chosen by the ophthalmologist is a healthy one so that it lasts for a lifetime.

But one must remember to find the right eye hospital and eye specialists to get their treatment done successfully.

 



Category :health
Author Website : Best Eye Hospital

Over 400 companies claim to possess the required expertise to offer regulatory affairs management-related services to medical device-focused business entities, claims Roots Analysis

Over 400 companies claim to possess the required expertise to offer regulatory affairs management-related services to medical device-focused business entities, claims Roots Analysis

- More than 130 medical devices were approved by the FDA since January 2018, while several are currently being evaluated across more than 9,500 (active) clinical trials, worldwide. Even though technical innovation has enabled the development of a variety of versatile medical devices, product approval, given stringent regulatory standards, is still a concern. To order this 550+ page report, which features 245+ figures and 250+ tables, please visit this link The USD 820 million (by 2030) financial opportunity within the contract regulatory affairs-management services market for medical devices has been analyzed across the following segments:  Medical Device Class  Class I  Class II  Class III  Therapeutic Area  Cardiovascular Disorders  CNS Disorders  Metabolic Disorders  Oncological Disorders  Ophthalmological Disease  Orthopedic Disorders  Pain Disorders  Respiratory Disorders  Others  Type of Regulatory Affairs Service  Pharmacies GAP-Analysis  Pharmacies Legal Representation  Pharmacies Notified Body Selection  Product Labelling-related Services  Product Registration and Clinical Trial Applications  Regulatory Document Submissions  Regulatory Writing and Publishing  Risk Management-related Services  Technical Dossier Set-up  Vigilance & Medical Device Report  Key Geographical Regions  North America  Europe  Asia-Pacific and Rest of the World The Contract Regulatory Affairs-Management Market for Medical Devices, 2019-2030 report features the following companies, which we identified to be key players in this domain:  CTI Clinical Trial and Consulting Services  CROMSOURCE  ICON  Intertek  Medpace  MIC Medical  North American Science Associates (NAMSA)  Parexel  PharmaLex  Premier Research  Société Générale de Surveillance (SGS)  Underwriters Laboratory (UL) Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Role of Regulatory Affairs in Medical Device Supply Chain 5. Regulatory and Reimbursement Landscape for Medical Devices 6. Competitive Landscape 7. Company Profiles 8. Competitive Benchmarking 9. Guide to Regulatory Outsourcing Models 10. Medical Device Regulatory Affairs: Key Performance Indicators 11. Market Forecast 12. Conclusion 13. Survey Insights 14. Executive Insights 15. Appendix 1: Tabulated Data 16. Appendix 2: List of Companies and Organizations To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html Contact Details Gaurav Chaudhary +1 (415) 800 3415 [email protected]


Health What You Silently Say And Do Is More Important Than What You Externally

Health What You Silently Say And Do Is More Important Than What You Externally

- Health What You Silently Say And Do Is More Important Than What You Externally Presently, let me get straight to the point


China reports a few new cases of COVID-19

China reports a few new cases of COVID-19

- China on Sunday reported 109 new confirmed COVID-19 cases, two-thirds of them in a northern province that abuts Beijing, and no deaths


Barcelona ready to hit back after transfer ban appeal fails

Barcelona ready to hit back after transfer ban appeal fails

- Follow us at @WorldSportCNN and like us on Facebook <br><br>The Catalan club hit back on Tuesday aft